Category: Hologic Inc.
Hologic fires its chief administrative officer, Mark Casey, effective Dec. 19.
Hologic's 4th-quarter and fiscal 2014 earnings top expectations as it reveals the sale of its MRI coils business to Philips Healthcare.
The Centers for Medicare & Medicaid Services approve new reimbursement codes for mammograms using 3D breast tomosynthesis technology, sending Hologic shares up today on Wall Street.
MRI Interventions taps Intuitive Surgical marketing & business development executive Frank Grillo to be its new CEO.
, Cynosure Inc.
, CytoSorbents Corp.
, Forward Industries
, Halloran Consulting Group
, Hologic Inc.
, Intuitive Surgical Inc.
, MRI Interventions
, Orthofix International
, Positron Corp.
, pSivida Corp.
Here's a look at some of the top Wall Street stories for medical device companies this week: Hologic's CEO praises its activist investor; Lantheus spikes IPO plans; Ex-CEO Pignatelli backs down, but not out, in spat with Biolase; Symmetry Medical sells its OEM biz to Tecomet for $450M; Valeant's hostile takeover hopes fade as Allergan war continues
Hologic CEO Steven MacMillan says activist investor Carl Icahn, who pushed his way into the board room last year, is "clearly not a micro-manager."
Hologic (NSDQ:HOLX) CEO Steven MacMillan offered a glowing review to major stakeholder Carl Icahn, saying that activist investor is "not into our shorts at all."
Hologic swings to fiscal 3rd-quarter profits despite flat sales growth and raises its sales and earnings forecasts for the rest of fiscal 2014.
Hologic (NSDQ:HOLX) swung to 3rd-quarter black during the 3 months ended June 28, despite flat sales growth of just 1%, and boosted its outlook for the rest of its fiscal year.